# MK-2206 and AZD6244 in Patients With Advanced Colorectal Carcinoma

> **NCT01333475** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 21 (actual)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **DRUG:** MK-2206 + AZD6244

## Key facts

- **NCT ID:** NCT01333475
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2013-11
- **Final completion:** 2014-09
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2015-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01333475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01333475, "MK-2206 and AZD6244 in Patients With Advanced Colorectal Carcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01333475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*